1. Home
  2. GSIT vs RNA Comparison

GSIT vs RNA Comparison

Compare GSIT & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSI Technology

GSIT

GSI Technology

HOLD

Current Price

$6.71

Market Cap

260.8M

Sector

Technology

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$12.21

Market Cap

222.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIT
RNA
Founded
1995
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
260.8M
222.5M
IPO Year
2004
2025

Fundamental Metrics

Financial Performance
Metric
GSIT
RNA
Price
$6.71
$12.21
Analyst Decision
Buy
Analyst Count
0
20
Target Price
N/A
$69.26
AVG Volume (30 Days)
667.1K
127.8K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,122,000.00
N/A
Revenue This Year
N/A
$88.12
Revenue Next Year
N/A
$18.11
P/E Ratio
N/A
N/A
Revenue Growth
22.44
N/A
52 Week Low
$2.82
$11.13
52 Week High
$18.14
$73.06

Technical Indicators

Market Signals
Indicator
GSIT
RNA
Relative Strength Index (RSI) 53.09 51.20
Support Level $5.21 $11.95
Resistance Level $7.61 $14.05
Average True Range (ATR) 0.49 0.39
MACD 0.18 0.05
Stochastic Oscillator 82.85 80.33

Price Performance

Historical Comparison
GSIT
RNA

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: